Our Best Shot: Long-Acting Injectables for the Treatment of Schizophrenia and Bipolar Disorder

All Sessions Will Be Held in Pacific Time (PT)

Despite advances in pharmacologic treatments, nonadherence remains a major challenge in the management of schizophrenia and bipolar disorder, often leading to relapse, hospitalization, and diminished quality of life. Long-acting injectables (LAIs) offer an effective solution to support sustained symptom control and improve treatment continuity, yet they remain underutilized in clinical practice. This program is designed to help mental health clinicians, especially prescribers, bridge that gap by providing practical strategies for integrating LAIs into personalized treatment plans. Attendees will explore communication techniques to address patient concerns, build therapeutic alliances, and collaborate across care teams, while also gaining essential knowledge of pharmacokinetics, formulation differences, and switching protocols to ensure safe and effective use of LAIs.



Saturday, September 27, 2025

7:00 am - 8:00 am

Say Yes to The Meds! Collaborating With Patients to Improve Treatment Adherence, Quality of Life, and Outcomes Using Long-Acting Injectables

Leslie Citrome, MD, MPH

8:00 am - 9:00 am

Industry Session

Sponsored by AbbVie, Inc.

9:00 am – 9:05 am

Break

9:05 am – 9:35 am

Poster Session

Sponsored by Teva Pharmaceuticals

9:35 am - 10:35 am

Kinect the Shots! Practical Guidance For Utilizing Long-acting Injectables

Jonathan M. Meyer, MD

10:35 am - 11:00 am



The content of all non-CME/CE events (Industry Symposia, Disease State Sessions, and Poster Sessions) and the views expressed therein are those of the presenting entity and not of NEI. These events are not part of the scientific program and do not provide CME/CE credit. By opening a non-CME/CE event, the attendee opts in to receive follow-up information from the commercial sponsor.



Program Faculty

Leslie Citrome, MD, MPH


Clinical Professor, Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY


Dr. Leslie Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. He is the Editor-in-Chief of the International Journal of Clinical Practice, published by Wiley. Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is now engaged as a consultant in clinical trial design and interpretation.

Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. Main areas of interest include schizophrenia, bipolar disorder, and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm.

Dr. Citrome is the author or co-author of over 400 research reports, reviews, and chapters in the scientific literature, is on the editorial board of 13 different medical journals, reviews for over 90 journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.

read more +

Jonathan M. Meyer, MD


Voluntary Clinical Professor, Department of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA


Dr. Jonathan Meyer is a Voluntary Clinical Professor of Psychiatry at University of California, San Diego, and a Distinguished Life Fellow of the American Psychiatric Association. Dr. Meyer is a graduate of Stanford University and Harvard Medical School, finished his adult psychiatry residency at LA County-USC Medical Center and completed fellowships there in Consultation/Liaison Psychiatry and Psychopharmacology Research. Dr. Meyer has teaching duties at UC San Diego and the Balboa Naval Medical Center in San Diego, and is a psychopharmacology consultant to the first episode psychosis programs at Balboa Naval Medical Center in San Diego and in the State of Nevada.

Dr. Meyer has lectured and published extensively on psychopharmacology, and is the sole author of the chapter on the Pharmacotherapy of Psychosis and Mania for the last 3 editions of Goodman & Gilman's The Pharmacological Basis of Therapeutics. Along with Dr. Stephen Stahl he is co-author of the Clozapine Handbook published in 2019, The Clinical Use of Antipsychotic Plasma Levels released in 2021, and The Lithium Handbook published in 2023, all three by Cambridge University Press.

read more +
Registration is Free but Required!